Q2 2025 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2025-08-14 · accession 0001940272-25-000005
$652.1M
Reported value
210
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 492327101 | KROS | KEROS THERAPEUTICS INC | $71.9M | 11.0% | 5,389,264 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $52.4M | 8.04% | 948,069 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $38.0M | 5.83% | 337,125 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $29.7M | 4.56% | 850,437 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $25.0M | 3.84% | 40,500 | PUT | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $23.5M | 3.60% | 3,071,340 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $21.9M | 3.35% | 1,940,797 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $20.5M | 3.14% | 3,375,009 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $19.2M | 2.95% | 582,147 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $14.0M | 2.15% | 22,684 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $13.6M | 2.09% | 523,216 | Common | SOLE |
| 78468R663 | BIL | SPDR SERIES TRUST | $12.4M | 1.91% | 135,585 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $11.2M | 1.72% | 259,659 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $10.0M | 1.53% | 5,122,105 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $9.0M | 1.37% | 847,227 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $8.7M | 1.34% | 2,825,773 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $8.6M | 1.32% | 875,983 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $8.6M | 1.31% | 535,066 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $8.2M | 1.26% | 3,600,670 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $8.1M | 1.25% | 259,503 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $8.0M | 1.23% | 1,937,123 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $8.0M | 1.22% | 750,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $7.7M | 1.18% | 1,205,101 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $7.0M | 1.07% | 3,081,414 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $7.0M | 1.07% | 3,009,870 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $6.6M | 1.01% | 721,599 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $6.3M | 0.96% | 783,217 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $6.1M | 0.94% | 264,900 | CALL | SOLE |
| G1000R101 | AAM | AA MISSION ACQUISITION CORP | $6.0M | 0.92% | 578,359 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $5.9M | 0.90% | 148,461 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $5.8M | 0.89% | 345,878 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $5.5M | 0.84% | 516,482 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $5.3M | 0.81% | 469,018 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $4.9M | 0.76% | 134,136 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $4.7M | 0.72% | 442,615 | Common | SOLE |
| 464287457 | SHY | ISHARES TR | $4.4M | 0.68% | 53,337 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $4.4M | 0.68% | 989,297 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $4.2M | 0.64% | 4,500,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.1M | 0.63% | 302,125 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $3.9M | 0.60% | 296,766 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $3.6M | 0.55% | 100,974 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $3.6M | 0.55% | 210,313 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $3.6M | 0.55% | 915,130 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $3.4M | 0.52% | 622,873 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.2M | 0.49% | 98,032 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.9M | 0.44% | 45,390 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $2.7M | 0.41% | 28,450 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $2.5M | 0.38% | 2,000,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.4M | 0.37% | 1,723,526 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.4M | 0.37% | 170,598 | Common | SOLE |
| G0544A103 | ASPC | A SPAC III ACQUISITION CORP | $2.2M | 0.34% | 215,000 | Common | SOLE |
| 21900C308 | CRMD | CORMEDIX INC | $2.2M | 0.33% | 175,000 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $2.1M | 0.33% | 100,000 | CALL | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.0M | 0.31% | 112,359 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $2.0M | 0.31% | 149,385 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $2.0M | 0.31% | 531,515 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $1.9M | 0.29% | 15,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $1.8M | 0.28% | 67,813 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $1.8M | 0.27% | 33,143 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $1.8M | 0.27% | 3,361 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $1.7M | 0.26% | 207,818 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $1.7M | 0.26% | 170,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.6M | 0.25% | 34,314 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $1.6M | 0.25% | 142,780 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $1.6M | 0.24% | 56,540 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $1.5M | 0.23% | 53,125 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.5M | 0.22% | 73,505 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.5M | 0.22% | 17,330 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $1.4M | 0.22% | 62,088 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.4M | 0.22% | 39,677 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.3M | 0.21% | 249,646 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.3M | 0.20% | 45,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.3M | 0.19% | 250,000 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $1.2M | 0.18% | 35,900 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $1.2M | 0.18% | 57,466 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $1.1M | 0.17% | 24,082 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $1.1M | 0.16% | 25,000 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $1.1M | 0.16% | 916,183 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $1.0M | 0.16% | 21,522 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $1.0M | 0.16% | 997,547 | Common | SOLE |
| G1069P137 | BSAAU | BEST SPAC I ACQUISITION CORP | $1.0M | 0.15% | 100,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $969,596 | 0.15% | 1,759 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $963,264 | 0.15% | 18,313 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $957,194 | 0.15% | 249,920 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $955,056 | 0.15% | 39,400 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $947,725 | 0.15% | 128,767 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $940,500 | 0.14% | 55,000 | CALL | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $919,398 | 0.14% | 13,962 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $904,400 | 0.14% | 35,000 | PUT | SOLE |
| 670703107 | NUVL | NUVALENT INC | $903,545 | 0.14% | 11,842 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $896,008 | 0.14% | 155,557 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $889,200 | 0.14% | 40,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $872,160 | 0.13% | 55,200 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $859,499 | 0.13% | 68,815 | Common | SOLE |
| G52443119 | KVAC | KEEN VISION ACQUISITION CORP | $852,750 | 0.13% | 75,000 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $841,530 | 0.13% | 420,765 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $784,780 | 0.12% | 18,070 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $746,291 | 0.11% | 114,814 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $713,191 | 0.11% | 149,830 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $686,678 | 0.11% | 237,605 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $675,710 | 0.10% | 275,800 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $675,110 | 0.10% | 147,404 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $674,592 | 0.10% | 85,826 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $662,192 | 0.10% | 166,799 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $640,509 | 0.10% | 5,100 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $622,058 | 0.10% | 441,176 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $608,236 | 0.09% | 63,424 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $600,582 | 0.09% | 34,124 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $583,338 | 0.09% | 145,109 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $583,292 | 0.09% | 13,366 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $567,428 | 0.09% | 326,108 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $557,286 | 0.09% | 7,040 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $529,647 | 0.08% | 204,497 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $524,582 | 0.08% | 176,627 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $524,400 | 0.08% | 40,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $522,603 | 0.08% | 104,730 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $509,743 | 0.08% | 34,051 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $503,100 | 0.08% | 10,000 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $499,667 | 0.08% | 35,716 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $483,100 | 0.07% | 10,000 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $481,280 | 0.07% | 167,111 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $456,332 | 0.07% | 32,341 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $442,894 | 0.07% | 29,625 | Common | SOLE |
| G6363K106 | — | NABORS ENERGY TRANSITION COR | $442,890 | 0.07% | 39,900 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $422,350 | 0.06% | 2,500 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $417,359 | 0.06% | 143,917 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $408,169 | 0.06% | 15,796 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $389,765 | 0.06% | 500 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $371,751 | 0.06% | 122,690 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $367,041 | 0.06% | 53,349 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $366,944 | 0.06% | 103,950 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $360,804 | 0.06% | 168,600 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $355,368 | 0.05% | 31,200 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $352,750 | 0.05% | 25,000 | CALL | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $318,983 | 0.05% | 1,054 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $311,100 | 0.05% | 15,000 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $309,685 | 0.05% | 27,285 | Common | SOLE |
| 45782T105 | INMB | INMUNE BIO INC | $300,762 | 0.05% | 130,200 | PUT | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $294,270 | 0.05% | 17,000 | Common | SOLE |
| G0131Y100 | ANSC | AGRICULTURE & NAT SOL ACQ CO | $293,623 | 0.05% | 27,062 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $291,830 | 0.04% | 2,750 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $279,490 | 0.04% | 227,228 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $269,353 | 0.04% | 4,900 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $268,562 | 0.04% | 26,937 | Common | SOLE |
| 462837105 | UCFI | IRON HORSE ACQUISITIONS CORP | $258,125 | 0.04% | 25,000 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $255,360 | 0.04% | 12,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $253,500 | 0.04% | 50,000 | PUT | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $248,629 | 0.04% | 79,945 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $242,684 | 0.04% | 209,210 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $241,985 | 0.04% | 1,402 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $235,881 | 0.04% | 142,958 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $230,037 | 0.04% | 351,094 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $219,560 | 0.03% | 23,063 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $212,509 | 0.03% | 22,875 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $197,911 | 0.03% | 34,300 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $190,400 | 0.03% | 20,000 | CALL | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $182,150 | 0.03% | 28,023 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $177,100 | 0.03% | 35,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $164,100 | 0.03% | 30,000 | Common | SOLE |
| G2283U100 | — | COLOMBIER ACQUISITION CORP I | $154,600 | 0.02% | 10,000 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $149,558 | 0.02% | 16,221 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $148,644 | 0.02% | 37,161 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $147,957 | 0.02% | 119,320 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $142,915 | 0.02% | 42,408 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $137,000 | 0.02% | 10,000 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $134,819 | 0.02% | 299,598 | Common | SOLE |
| 18914F103 | CLOV | CLOVER HEALTH INVESTMENTS CO | $134,757 | 0.02% | 48,300 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $134,600 | 0.02% | 10,000 | Common | SOLE |
| G7257A113 | PCAPU | PROCAP ACQUISITION CORP | $114,490 | 0.02% | 10,680 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $113,364 | 0.02% | 37,788 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $113,050 | 0.02% | 10,000 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $108,129 | 0.02% | 18,643 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $107,068 | 0.02% | 101,008 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $105,988 | 0.02% | 28,415 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $101,145 | 0.02% | 27,787 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $97,571 | 0.01% | 43,173 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $96,800 | 0.01% | 10,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $96,616 | 0.01% | 10,400 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $95,339 | 0.01% | 82,189 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $93,650 | 0.01% | 10,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $85,000 | 0.01% | 50,000 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $84,700 | 0.01% | 10,000 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $81,514 | 0.01% | 102,948 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $78,039 | 0.01% | 130,000 | Common | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $67,520 | 0.01% | 170,506 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $65,000 | 0.01% | 25,000 | Common | SOLE |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $62,449 | 0.01% | 10,823 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $58,000 | 0.01% | 50,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $54,286 | 0.01% | 118,012 | Common | SOLE |
| G1933S101 | CASIF | CASI PHARMACEUTICALS INC | $52,062 | 0.01% | 44,120 | Common | SOLE |
| G1000R127 | — | AA MISSION ACQUISITION CORP | $49,702 | 0.01% | 505,099 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $45,799 | 0.01% | 16,900 | Common | SOLE |
| 451033708 | IBIO | IBIO INC | $41,832 | 0.01% | 54,819 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $38,225 | 0.01% | 115,867 | Common | SOLE |
| G0544A145 | ASPCR | A SPAC III ACQUISITION CORP | $36,550 | 0.01% | 215,000 | Common | SOLE |
| G63365103 | MURA | MURAL ONCOLOGY PUB LTD CO | $29,282 | 0.00% | 11,855 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $26,154 | 0.00% | 19,889 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $23,900 | 0.00% | 10,000 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $22,591 | 0.00% | 20,352 | Common | SOLE |
| 603380205 | NERV | MINERVA NEUROSCIENCES INC | $21,338 | 0.00% | 12,406 | Common | SOLE |
| G5212E113 | — | JVSPAC ACQUISITION CORP | $20,880 | 0.00% | 24,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $20,400 | 0.00% | 10,000 | Common | SOLE |
| 62459M206 | — | MOVANO INC | $13,019 | 0.00% | 19,146 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $11,854 | 0.00% | 39,925 | Common | SOLE |
| 207523101 | — | CONNECT BIOPHARMA HLDGS LTD | $10,094 | 0.00% | 10,300 | Common | SOLE |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $7,581 | 0.00% | 10,366 | Common | SOLE |
| 462837121 | — | IRON HORSE ACQUISITIONS CORP | $6,140 | 0.00% | 12,320 | Common | SOLE |
| G52443127 | KVACW | KEEN VISION ACQUISITION CORP | $4,050 | 0.00% | 75,000 | Common | SOLE |
| G3034H141 | EMCRF | EMBRACE CHANGE ACQUISITN COR | $1,501 | 0.00% | 13,144 | Common | SOLE |
| G3034H125 | EMCWF | EMBRACE CHANGE ACQUISITN COR | $360 | 0.00% | 18,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.